Skip to main content

Drug Interactions between Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca and ceftriaxone

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

cefTRIAXone parenteral nutrition solution w/electrolytes

Applies to: ceftriaxone and Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca (parenteral nutrition solution w/electrolytes)

CefTRIAXone and calcium can form crystals when they are mixed together in solution or in the bloodstream. Life-threatening and fatal reactions have occurred when the crystals accumulated in the lung and kidneys of newborns. If you (or your child) require treatment with cefTRIAXone and parenteral nutrition solution w/electrolytes by injection directly into the veins, your healthcare providers can help prevent this interaction by taking a few simple precautions. You should tell your healthcare providers about all the medications that have been given to you (or your child) in the past two days, especially those given through the veins. Do not stop using any medications without first talking to your healthcare providers.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer